Prognostic value of serum gamma-glutamyl transferase activity after myocardial infarction

Abstract

Aims Serum gamma-glutamyl transferase activity (γ-GT) is able to catalyse low-density lipoprotein oxidation and has been detected in coronary atherosclerotic plaques. γ-GT has been documented as an independent risk factor for cardiac mortality in middle-aged men. The purpose of this study is to determine the prognostic value of γ-GT in patients with coronary artery disease. Methods and Results In a prospective study, γ-GT and other cardiac risk factors were evaluated in 469 consecutive subjects with angiographically documented coronary artery disease, using mortality and mortality plus non-fatal myocardial infarction as end-points. γ-GT showed an independent prognostic value beyond known established risk factors in the subgroup of 262 patients with previous myocardial infarction. At a 6-year follow-up, cardiac mortality was 25·2% in patients with γ-GT >40U.l⁻¹vs 13·9% in those with γ-GT 40U.l⁻¹and in 20·4% of those with levels 40U.l⁻¹, previous myocardial infarction, and multiple vessel disease identified a subgroup of 168 patients with the highest risk of cardiac events at 6 years (P=0·024). The relationship between γ-GT levels and cardiac events remained significant after adjustment for cardiac risk factors, and possible confounders, including alcohol consumption. γ-GT did not show significant prognostic value in the 207 patients without previous myocardial infarction. Conclusionγ-GT is an independent cardiac risk factor in ischaemic patients with established coronary atherosclerosis and previous myocardial infarction.